ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,313Medicare Part D Prescriptions Filled, Including Refills

Rank: 856 out of 3647

$565K Total Retail Price of All Prescriptions

Rank: 888 out of 3647

733 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 733 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 733 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,844 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 647 596 1 1
AMLODIPINE BESYLATE 525 454 2 2
PRAVASTATIN SODIUM 402 350 3 16
OMEPRAZOLE 378 328 4 3
LISINOPRIL 326 273 5 4
METFORMIN HCL 317 241 6 6
HYDROCHLOROTHIAZIDE 275 253 7 9
LEVOTHYROXINE SODIUM 209 191 8 5
ALENDRONATE SODIUM 205 201 9 23
ATENOLOL 204 171 10 10
METOPROLOL TARTRATE 195 160 11 7
ZETIA 178 171 12 96
FUROSEMIDE 164 137 13 8
GLYBURIDE 161 119 R 14 54
ATORVASTATIN CALCIUM 156 142 15 13
HYDROCODONE-ACETAMINOPHEN 144 83 S3 16 12
CITALOPRAM HBR 140 124 17 25
METOPROLOL SUCCINATE 137 135 18 18
FLUTICASONE PROPIONATE 122 120 19 32
ZOLPIDEM TARTRATE 110 110 20 14
LOVASTATIN 110 90 20 21
ENALAPRIL MALEATE 107 98 22 35
ACETAMINOPHEN-CODEINE 104 87 S3 23 149
WARFARIN SODIUM 93 79 24 15
FENOFIBRATE 93 90 24 50
SERTRALINE HCL 87 78 26 27
POTASSIUM CHLORIDE 86 81 27 24
GABAPENTIN 79 59 28 17
ROPINIROLE HCL 78 49 29 151
RANITIDINE HCL 77 63 30 29
LOSARTAN POTASSIUM 76 75 31 11
TRAMADOL HCL 76 70 31 22
DIGOXIN 72 63 33 51
GLIPIZIDE 72 56 33 41
CEFDINIR 71 63 35 330
TAMSULOSIN HCL 70 67 36 28
OXYBUTYNIN CHLORIDE 69 56 37 107
ADVAIR DISKUS 69 51 37 52
ALLOPURINOL 69 63 37 37
AZITHROMYCIN 66 55 40 34
BENAZEPRIL HCL 66 54 40 71
CARVEDILOL 66 54 40 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 60 43 36
PROAIR HFA 64 34 44 62
BUSPIRONE HCL 63 47 45 162
DOXAZOSIN MESYLATE 59 59 46 57
AMOXICILLIN 58 48 47 133
CALCITONIN-SALMON 57 52 48 297
ALPRAZOLAM 51 40 49 31
CEPHALEXIN 51 47 49 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.